ERBB2 and breast cancer: This discrepancy could first be explained by difference in clinical characteristics between Dundee and TCGA series, in particular regarding repartition of intrinsic breast cancer subtypes (ER+/− PR− HER2+: Dundee 36.5% vs. TCGA 21.8%) (Table 1 and Table S1), and choice of cut-off.